Russia has announced that it has developed an “antidote” against Wuhan coronavirus (COVID-19) infections. The country’s medical regulator touted the new drug’s efficacy rate of “more than 99 percent” based on previous studies. If clinical trials are successful, Russia’s new drug will be the first etiotropic COVID-19 medication – a treatment that directly targets the cause of … Continue reading Russia developing coronavirus antidote with a reported 99% efficacy rate
